News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
-
04 14 2021 GENEVA--(BUSINESS WIRE)--The Commons Project Foundation and the World Economic Forum today announced the global expansion of the CommonTrust Network (www.commontrustnetwork.org) to cover 32...
-
04 13 2021 10 studies highlight Quest Diagnostics' commitment to specialty genetics testing and research in areas such as mitochondrial mtDNA analysis and next generation sequencingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Blueprint Genetics announced today that they will present results of 10 studies at the virtual...
04 13 2021 Our Media Statement about COVID-19 Testing This is an evolving situation. Please check back to this page periodically for the latest information For more information, members of the media may...
-
04 07 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2021 financial results on Thursday, April...
-
04 01 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the sale of its minority share in Q2 Solutions to IQVIA (NYSE: IQV), a leading...
-
03 15 2021 Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throughput, health-economic value-added clinical methods,...
-
03 11 2021 - Company to repurchase $900 million of its shares in first half of 2021At a virtual meeting with analysts and investors at its Investor Day, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...
-
03 08 2021 Quest to acquire Mercy's outreach laboratory business serving providers and patients in Arkansas, Kansas, Missouri and OklahomaQuest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, and Mercy, one of the nation's most highly integrated, multi-state health care systems, today announced a...
-
03 02 2021 -Quest will remain the exclusive, national clinical reference laboratory and testing provider for BlueCross BlueShield of Western New York and BlueShield of Northeastern New York members for all products-SECAUCUS, N.J., March 2, 2021— BlueCross BlueShield of Western New York and BlueShield of Northeastern New York, two of New York’s leading insurance carriers, and Quest Diagnostics (NYSE:...
-
03 02 2021 Collaboration empowers individuals to access professional medical advice, when and where they want it, for employer-sponsored laboratory and biometric screening98point6, the on-demand digital primary care service that delivers personalized diagnosis, treatment and consultation to patients across the country, today announced a collaboration with Quest...
-
02 24 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new COVID-19 testing service that aids in providing insight into an individual's...
-
02 23 2021 --Daniel C. Stanzione to Retire from Board and as Lead Independent DirectorQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced changes in the leadership of its Board of Directors. Daniel C. Stanzione,...
-
02 23 2021 -- Quest Diagnostics to Provide Blood Specimen Collection for Galleri Through its Patient Service Centers and Mobile Phlebotomists --MENLO PARK, Calif.-- GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced an agreement with Quest Diagnostics (NYSE: DGX), the leading...
-
02 16 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at Citi's 2021 Healthcare Services, Medtech,...
02 16 2021 - Quest will remain the preferred national clinical reference laboratory and testing provider for EmblemHealth and ConnectiCare members for all productsEmblemHealth, one of the nation's largest non-profit health insurers, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, have renewed their...
02 11 2021 Quest Diagnostics has been named a Best Place to Work for LGBTQ Equality by scoring a perfect 100 on the Human Rights Campaign Foundation’s 2021 Corporate Equality Index (CEI) for the fifth...
-
02 09 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will host a virtual Investor Day for institutional investors and financial analysts on Thursday,...
-
02 04 2021 - Fourth quarter revenues of $3.0 billion, up 55.8% versus 2019Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
-
02 04 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the Company's Board of Directors has authorized a 10.7% increase in its...
-
02 01 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2021...
-
01 26 2021 First COVID-19 testing event launched by a partnership among Quest Diagnostics, Choose Healthy Life and United Way of New York City at Harlem's historic Abyssinian Baptist ChurchIn response to the disproportionate and devastating impact COVID-19 has had on Black communities and other underserved communities of color, the first of many "Choose Healthy Life" COVID-19...
-
01 18 2021 Leading public health officials Dr. Anthony Fauci, Dr. Marcella Nunez-Smith and Dr. Tom Frieden were among featured speakers and Q&A participantsToday, on Martin Luther King Jr. Day, a group of the nation's most renowned Black clergy led by Rev. Al Sharpton and Rev. Calvin O. Butts, III hosted the Choose Healthy Life Black Clergy Conclave....
-
01 18 2021 By magnifying racial disparities in healthcare, COVID-19 has raised expectations for changeA new Quest Diagnostics Health Trends™ study finds that Black and Hispanic/Latinx Americans are nearly two times as likely as White Americans to say their access to COVID-19 vaccines, treatments...
-
01 18 2021 Quest's genomic sequencing and infectious disease expertise will identify novel SARS-CoV-2 mutations, providing insights on prevalence and transmission in the United StatesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into an agreement with the Centers for Disease Control and...
-
01 15 2021 On Martin Luther King Jr. Day, one year after the last MLK Day saw the first confirmed case of COVID-19 in the United States, Choose Healthy Life, led by Rev. Al Sharpton and Rev. Calvin O. Butts,...
-
01 13 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2020 results on Thursday,...
-
12 22 2020 Hackensack Meridian Health (HMH), the largest, most comprehensive and truly integrated health care network in New Jersey, and Quest Diagnostics (NYSE: DGX), the world's leading provider of...
-
12 17 2020 Rev. Al Sharpton and Rev. Calvin Butts, national co-chairs of the Choose Healthy Life Black Clergy Action Plan, convened nation's top Black clergy for historic discussion on COVID-19 and health disparitiesChoose Healthy Life Black Clergy Action Plan, a group of the nation's leading Black clergy led by Rev. Al Sharpton and Rev. Calvin O. Butts, III, convened a meeting yesterday with Dr. Anthony...
-
12 17 2020 Android device users can now securely collect, store and share personal health data, including COVID-19 test results, from a single appQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and The Commons Project, a non-profit public trust dedicated to building and operating global...
-
12 16 2020 - Revenues for full year 2020 expected to be at least $9.35 billion versus the previous outlook of $8.8-$9.1 billionQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today raised its financial outlook for full year 2020. Since the company reported its...
12 09 2020 Nationwide survey believed to be the first to reveal insights into U.S. consumer behaviors and attitudes toward COVID-19 testing and health effects since fall-winter COVID-19 wave beganA new Quest Diagnostics Health Trends™ study finds that three in four Americans who believed they needed a COVID-19 test (74%) chose not to get one, or delayed getting one, primarily due to...
-
12 08 2020 Quest’s industry-leading lab expertise will support Ro’s expansion in the treatment and management of chronic and complex conditions requiring diagnostic dataRo, the healthcare technology company, and Quest Diagnostics (NYSE: DGX), the nation’s leader in diagnostic information services, today...
-
11 24 2020 Award follows a series of other recognitions for HealthyQuest, the company's employer population health programQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2020 Workplace...
-
11 23 2020 Rev. Al Sharpton and Rev. Calvin Butts launch the Choose Healthy Life Black Clergy Action Plan to Offer COVID-19 Testing through the Black ChurchNew York, NY – November 23, 2020: Today, a group of the Nation’s renown Black clergy led by Rev. Al Sharpton and Rev. Calvin O. Butts, III, announced a historic partnership with United Way of...
-
11 23 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced professional lab services relationships with two hospital health systems to enhance...
-
11 18 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.56 per share,...
-
11 16 2020 Collaboration will include COVID-19 IgG antibody testing for up to 1,000 study participantsBOSTON, NEW YORK, SECAUCUS, NJ- Nov. 16, 2020 - Today, Dana-Farber Cancer Institute, one of the world’s leading centers of cancer research and treatment, and Quest Diagnostics, (NYSE: DGX), the...
-
11 03 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Credit Suisse 29th Annual Virtual...
-
10 27 2020 First collaboration of virtual care provider and national laboratory provider features self-collected at-home specimen collection and mental health care support to empower diverse workforces to access health care safelyQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Catapult Health, the leading national provider of employer-sponsored Preventive Checkups, have...
-
10 22 2020 - Third quarter revenues of $2.79 billion, up 42.5% from 2019Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2020....
-
10 15 2020 Quest Diagnostics Recognized for Offering One of the Nation's Best Workforce Health and Well-being Initiatives for Third Year in a RowQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received the 2020 Best Employers: Excellence in Health & Well-Being...
-
10 15 2020 Largest nationally representative study based on laboratory data shows double-digit increases in mixing of fentanyl with amphetamines and cocaineA new Quest Diagnostics Health Trends study indicates that misuse of fentanyl, heroin and nonprescribed opioids are on the rise, potentially due to the COVID-19 pandemic's impact on healthcare...
-
10 14 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received the prestigious C. Everett Koop National Health Award for 2020....
-
10 13 2020 Qualified residents in close proximity to Cheektowaga Walmart may be able to receive at-home self-collection kits by drone deliveryCHEEKTOWAGA, NY – Oct. 13 –Walmart, Quest Diagnostics, and DroneUp today announced a pilot program to provide drone delivery of COVID-19 at-home self-collection kits to single-family homes in...
-
10 05 2020 Nationwide Collaboration Creates Multi-Layered Approach to Public Health SafetyToday, CLEAR, the secure identity company, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced a new collaboration that aims to foster...
-
10 01 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2020 results on Thursday, October 22, 2020,...
-
09 30 2020 Nearly 20 Viral and Bacterial Infections Can Be Identified from a Single Swab, Reducing Time to Diagnose and TreatHealthcare providers across the United States can now access three different test options from Quest Diagnostics (NYSE: DGX) to aid the diagnosis of COVID-19 and differentiate it from other...
-
09 22 2020 Qualified residents in close proximity to North Las Vegas Walmart may be able to receive at-home self-collection kits by drone deliveryNORTH LAS VEGAS, NV – Sept. 22 –Walmart, Quest Diagnostics, and DroneUp today announced a pilot program to provide drone delivery of COVID-19 at-home self-collection kits to single-family...
09 17 2020 QuestDirect™ Active Infection allows individuals to collect a specimen at home or by drive-thru at more than 500 Walmart Neighborhood Market locationsIndividuals can now purchase a test to diagnose COVID-19 online, without visiting a doctor's office, through QuestDirect, the consumer-initiated testing business of Quest Diagnostics (NYSE: DGX),...
-
09 11 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 18th Annual Global...
-
09 10 2020 - Revenues for full year 2020 now expected to be $8.4-8.8 billion compared to the previous outlook of $8.0-8.6 billionQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today updated its financial outlook for full year 2020. Since the company reported its...
-
09 03 2020 Analysis of 18 million de-identified lab tests also reveals shift in positivity rate toward older women, with more females "aging out" of annual screening guidelines that end at age 25The rate at which women 18-30 years of age tested positive for the two most common reportable sexually transmitted infections grew by double digits between 2010 and 2017, finds an analysis of...
-
09 02 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Wells Fargo Virtual Healthcare...
08 25 2020 Marijuana positivity climbed by double digits across nearly all employee testing categories, while opiate and heroin positivity declineThe rate of workforce drug positivity hit a sixteen-year high in 2019, according to a new analysis released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic...
-
08 24 2020 Quest to dedicate more than $100 million to expand access to testing, partner to help those hit hardest by COVID-19 and fund Foundation initiativesQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, and the Quest Diagnostics Foundation, today announced a wide-ranging initiative to...
-
08 18 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.56 per share,...
-
08 17 2020 - Multi-regional strategic initiatives agreement designed to improve efficiency in care delivery, reduce cost, and enhance experience for health care consumers and providers.Anthem Inc. (NYSE: ANTM) and Quest Diagnostics (NYSE: DGX) have entered into a strategic relationship by collaborating on a variety of outcomes-based programs designed to create an improved health...
-
08 12 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today released its Annual Environmental, Social & Governance Report for 2019. The...
-
08 03 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed its previously announced acquisition of its joint venture...
08 03 2020 Next generation sequencing offers more comprehensive data on more commonly inherited health conditionsA new innovation in advanced genetic sequencing automation from Quest Diagnostics (NYSE: DGX) will now enable individuals to access highly accurate genetic testing providing insights into...
07 29 2020 Technique to increase COVID-19 molecular diagnostic testing capacity and provide faster test results reportingQuest Diagnostics (NYSE:DGX) today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for a new laboratory technique that speeds the process...
-
07 23 2020 - Second quarter revenues of $1.83 billion, down 6.4% from 2019Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2020, which are...
07 18 2020 First FDA authorization of laboratory technique for use in COVID-19 diagnostic testingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug...
07 15 2020 SECAUCUS, N.J., July 15, 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2020 Disability Equality...
-
07 13 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today preliminary financial results for the second quarter ended June 30,...
-
07 08 2020 Largest study of a nationally representative American population demonstrates cotesting outperforms HPV or Pap testing alone in detecting cancer and precancer in women 30 years and olderA Health Trends™ study from researchers at Quest Diagnostics (NYSE: DGX) and the University of Pittsburgh Medical Center (UPMC) provides new evidence that the HPV screening test is significantly...
-
06 30 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, marks its 10-year anniversary as a CEO Cancer Gold Standard™ employer this year, signifying its...
-
06 23 2020 Quest to manage approximately 30 hospital labs for the two health systems in separate professional lab services agreementsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the formation of a definitive multi-pronged agreement designed to optimize the...
-
05 29 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Virtual Healthcare Conference....
-
05 29 2020 COVID-19 tests will be distributed each week to St. Louis area Federally Qualified Health CentersHome State Health announced a collaboration with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to increase access to real-time reverse...
05 28 2020 Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channelsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug...
05 27 2020 COVID-19 molecular diagnostic and serology antibody testing at core of new suite of servicesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today launched a new suite of Return to Work services built around large-scale workforce COVID-19...
-
05 20 2020 TRENTON – Governor Phil Murphy, Walmart, and Quest Diagnostics today announced that seven Walmart stores across New Jersey will open COVID-19 drive-thru testing sites beginning on May 22. The...
-
05 20 2020 1,000 COVID-19 test kits will be distributed each week to Federally Qualified Health Centers in ArkansasArkansas Health & Wellness and Arkansas Total Care announced today a collaboration with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to increase...
-
05 18 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.56 per share,...
-
05 11 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $550 million aggregate principal...
-
05 08 2020 1,000 COVID-19 test kits will be distributed each week to Federally Qualified Health Centers in GeorgiaATLANTA, GA – Peach State Health announced today a collaboration with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, to increase access to...
-
05 05 2020 Quest Diagnostics Incorporated (NYSE: DGX) today announced that its 2020 Annual Meeting of Stockholders (the "Annual Meeting") will now be held solely by remote communication through a live,...
-
04 29 2020 Company to join forces with Quest Diagnostics to expand access to COVID-19 testing at critical safety net providers across the countryCentene (NYSE: CNC) announced today a collaboration with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to increase access to real-time reverse...
04 28 2020 Provides physician-guided insight into COVID-19 immune response without a visit to the doctorBeginning today, individuals can purchase COVID-19 antibody testing for themselves online, without visiting a doctor's office, through QuestDirect, the consumer-initiated testing business of Quest...
-
04 22 2020 - First quarter revenues of $1.82 billion, down 3.7% from 2019Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2020. "We were...
04 21 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood...
-
04 09 2020 CareDx Collaborates with ExamOne, a Quest Diagnostics Company, to Expand Mobile Phlebotomy Coverage Across the United States for Transplant Patients who are High Risk for COVID-19SOUTH SAN FRANCISCO, Calif., April 09, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically...
-
04 07 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2020 results on Wednesday, April 22, 2020,...
-
03 21 2020 Individuals Who are 60 Years or Older or Who Have Other High-Risk Factors for Adverse COVID-19 Outcomes to Receive VIP Access During First Hour of Each DayThrough its "Peace of Mind" program, Quest Diagnostics (NYSE: DGX) is taking extra measures to ensure individuals who are the most vulnerable to adverse COVID-19 outcomes have special VIP-level...
03 12 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Mr. Wright L. Lassiter III to serve as a...
03 05 2020 Aim of new service is to supplement public health response in the United StatesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it will launch a coronavirus (COVID-19) test service. The new test service aids the...
-
02 26 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in...
-
01 30 2020 - Record fourth quarter revenues of $1.93 billion, up 4.8% versus 2018Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
-
01 27 2020 Quest to Acquire Memorial Hermann Diagnostic Laboratories and Professionally Manage its Hospital Laboratories in Greater HoustonQuest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, and Memorial Hermann Health System, a leading not-for-profit health system that includes 17 hospitals and...
-
01 22 2020 Acquisition adds platform in gene variant interpretation based on next generation sequencing and proprietary bioinformatics to improve patient care and drug developmentQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has acquired Blueprint Genetics in an all-cash equity transaction. Blueprint...
-
01 21 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2020...
-
01 08 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2019 results on Thursday,...
-
01 03 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 38th Annual J. P. Morgan Healthcare...
-
12 09 2019 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $800 million aggregate principal...
-
12 02 2019 Quest Diagnostics Acquires the Clinical Laboratory Services of Boston Clinical Laboratories in Massachusetts SECAUCUS, N.J. -- December 2, 2019 — Quest Diagnostics (NYSE:DGX), the world’s...
-
11 20 2019 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share,...
-
11 14 2019 Other Company Research Demonstrates the Value of Diagnostic Insights in Early Cardiovascular Disease Detection in Clinical and Workplace SettingsA laboratory test that evaluates high-density lipoprotein (HDL) cholesterol function provides unique and novel information for assessing cardiovascular disease risk, according to data presented...
-
11 05 2019 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2019 Workplace...
-
10 22 2019 - Third quarter revenues of $1.96 billion, up 3.5% from 2018Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2019. "We...